MoneyWorks4Me

Accretion Nutraveda informs about disclosures

17 Feb 2026 Evaluate
Accretion Nutraveda has informed that The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Unicorn Fund.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1741.55
Dr. Reddys Labs. 1225.45
Cipla 1329.00
Lupin 1915.45
Zydus Lifesciences 1125.80
View more..